Tsingke Showcases Workflow for Advancing Antibody Candidates at PEGS Europe 2026

Tsingke Showcases Effective Antibody Candidate Evaluation at PEGS Europe 2026



At PEGS Europe 2026 held in Lisbon, Tsingke presented a comprehensive strategy for biotechnology teams aiming to evaluate and advance their antibody candidates. With a firm belief that the initial binding of an antibody to its target is critical for drug discovery, R&D teams face the challenge of determining which candidates are viable for further development.

Steps in Antibody Evaluation


The event highlighted various key steps necessary for the successful progression of antibody candidates. This involves generating reliable data that allows R&D teams to make informed decisions about which candidates to pursue. Tsingke has developed an integrated workflow that encompasses several critical components of antibody discovery, from recombinant expression to engineering and characterization.

Identifying Viable Candidates


Starting with initial antibody hits, biotechnology teams often need to convert their findings from immune samples or existing hybridoma clones into a manageable set of recombinant antibodies. Tsingke employs a single B-cell screening workflow, which effectively preserves the natural pairing of heavy and light chains of antibodies. This approach is supplemented by hybridoma sequencing to recover valuable sequences from existing clones.

Once the candidates are expressed, they can be evaluated using various binding assays tailored for the specific project needs. Choices such as cell-based binding assays using flow cytometry or binding kinetics measurements through Biolayer Interferometry (BLI) or Surface Plasmon Resonance (SPR) allow teams to prioritize their candidates for further testing.

Assessing Binding Properties Across Formats


As the development period progresses, it's crucial for teams to ascertain whether the antibody maintains its desired binding properties when transitioned into different formats such as Fab or scFv. Tsingke supports teams in this phase with recombinant expression and binding characterization, enabling comparisons across formats before committing to extensive studies. For programs requiring diverse binding characteristics at varying pH levels, additional pH-dependent screening and engineering services are offered, ensuring that the characterization aligns with the specific program objectives.

Addressing Antibody-Oligonucleotide Conjugates


For teams investigating antibody-oligonucleotide conjugates (AOCs), having characterized samples for subsequent testing is paramount. Tsingke seamlessly integrates antibody production along with oligonucleotide synthesis, conjugation, and purification services, coupled with LC-MS characterization. The analytical data produced empowers teams to evaluate the conjugated materials effectively, leading to informed decisions regarding selection of samples for functional evaluation.

Yuan Wu, Tsingke's International Business Development Manager, emphasizes the tailored approach taken when collaborating with clients. “Teams come to us at various stages of their development. Some might have early antibody hits needing consistent comparison methods, while others may already have a lead and require insights into how format changes or conjugation impact the molecules they wish to test.” This allows Tsingke to align its production and characterization endeavors precisely with the teams’ strategic needs.

About Tsingke


Established as a reliable partner for pharmaceutical, biotechnology, and academic teams, Beijing Tsingke Biotech Co., Ltd. specializes in molecular biology and biologics research services. Their extensive portfolio includes custom DNA and RNA synthesis, antibody discovery, recombinant protein production, antibody engineering, and analytical characterization. To stay updated with Tsingke's advancements, follow them on LinkedIn.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.